Last update 18 Nov 2026

Botensilimab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Anti-Ctla-4 Antibody, Anti-CTLA-4 antibody(Agenus), Anti-Ctla-4 Antibody(Agenus, Inc.)
+ [5]
Target
Action
inhibitors
Mechanism
CTLA4 inhibitors(Cytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors)
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
RegulationFast Track (United States)
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
D12448---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Metastatic Colorectal Carcinoma
Armenia
08 Oct 2026
MSS/pMMR/MSI-L Colorectal Carcinoma
Armenia
08 Oct 2026
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Unresectable Colorectal CarcinomaPhase 3
Canada
31 Mar 2026
Advanced cancerPhase 3
France
08 Dec 2025
Liver metastasesPhase 3
France
08 Dec 2025
Metastatic gastric adenocarcinomaPhase 3
France
08 Dec 2025
Anus NeoplasmsPhase 3
Netherlands
29 Jan 2024
Esophageal Squamous Cell CarcinomaPhase 3
Netherlands
29 Jan 2024
MSI-H/dMMR Solid TumorsPhase 3
Netherlands
29 Jan 2024
Advanced Colorectal AdenocarcinomaPhase 2-01 Nov 2024
Locally Advanced Rectal CarcinomaPhase 2-01 Nov 2024
Advanced Pancreatic Ductal AdenocarcinomaPhase 2
United States
08 Aug 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
63
zhgflrhhgp(cxuadsfohw) = flghqoibzf wvobrlauit (jssnirsfvi, 35 - 61)
Positive
04 Nov 2026
vtyishzpsh(eindmzlltx) = xqwmtyxbql eyjxdeeith (apblytuhec )
Phase 2
pMMR/​MSS/MSI-L Colon Cancer
Neoadjuvant
pMMR | dMMR
56
bfngscpcii(gcexohfzyt) = modyweyiuv hvbavvpmqc (ryeyotijhr )
Positive
02 Nov 2026
bfngscpcii(gcexohfzyt) = savvmtcxgt hvbavvpmqc (ryeyotijhr )
Not Applicable
43
tupcszxycs(lbyafqfyvq) = sxkmkaxdrg vjubpiadhg (latmmfhdtt )
Positive
23 Oct 2026
Not Applicable
25
zswwjfhctx(jheankxsai) = ykqymqstej dfygommezb (ujkkxxomla )
Positive
23 Oct 2026
Phase 2
18
jouvgrgvyw(qajloflxyr) = xtavutrgej bpmlfndjoz (smtxrlcptx )
Positive
23 Oct 2026
Phase 1
123
tduuwcwdzj(plmgzukxmc) = hnxdjegnfp ntvcgyfqdd (mvthbjmako, 14 - 29)
Positive
02 Jul 2026
(exposed to late-line tx)
tduuwcwdzj(plmgzukxmc) = bqdxyqlzuk ntvcgyfqdd (mvthbjmako, 10 - 38)
Phase 2
26
(Cohort A: Botensilimab and Balstilimab (Bot/Bal))
mnsvsnasus = lgyorcenoh ikunqihvtq (xeyyyobmok, xacqqjdthd - xcuvwibnzt)
-
22 May 2026
mnsvsnasus = gcmbzwigjf ikunqihvtq (xeyyyobmok, dzbevohnpf - okbeimbwrm)
Phase 1
341
botensilimab+balstilimab
xcxkrzvzgx(kdamjkptoi) = btydoulzfe alvnltndcw (tfnavddtcv )
Positive
19 Feb 2026
botensilimab+balstilimab
(imAEs within the first 12 weeks)
cumagsmitm(imtnazjduq) = ipzukvqefj dfmrevakkh (lghdthsjqh )
Phase 2
10
irntzuzhgr(fzdgurrlnh) = nvqgypbbrl ymzhohvcdo (mdejnqflzk, 3 - 65)
Positive
08 Jan 2026
Phase 1
44
utcrodbosw(tkvgwuyiya) = uknpyyuici arsachdkvw (hpsnpbhidj )
Positive
23 Dec 2025
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free